Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

U.S. Cath Labs Companies and Market Forecast

Date : 09 June 2026

Who are the U.S. Cath Labs Market Top Companies and What are Their Offerings?

U.S. Cath Labs Market Companies are GE HealthCare, Abbott Laboratories, Koninklijke Philips N.V., Edwards Lifesciences Corporation, Siemens Healthineers AG, Merit Medical Systems, Inc., Medtronic plc, Cordis, , Terumo Medical Corporation

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
GE HealthCare Chicago, Illinois USA Dominant global cath lab imaging & interventional systems provider Fluoroscopy systems, interventional imaging suites
Siemens Healthineers Erlangen Germany Leading provider of cath lab imaging and hybrid OR solutions ARTIS pheno, angiography systems
Philips Amsterdam Netherlands Strong leader in image-guided therapy platforms Azurion cath lab systems, IVUS/OCT integration
Medtronic Minneapolis, Minnesota USA Major cardiovascular device provider for interventional procedures Stents, TAVR systems, cardiac ablation tools
Abbott Laboratories Abbott Park, Illinois USA Strong cath lab device and structural heart portfolio MitraClip, vascular closure, coronary stents
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Boston Scientific Marlborough, Massachusetts USA Major interventional cardiology device provider Coronary stents, IVL (Shockwave legacy), balloon catheters
Terumo Corporation Tokyo Japan Strong vascular access and interventional tools provider Guidewires, catheters, inflation devices
Canon Medical Systems Tochigi Japan Imaging systems used in cath labs Angiography and cardiovascular imaging systems
Edwards Lifesciences Irvine, California USA Leader in structural heart interventions TAVR systems (Sapien valve platform)
Teleflex Wayne, Pennsylvania USA Critical vascular access and interventional devices Catheters, guidewires, Arrow vascular sys
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Merit Medical Systems South Jordan, Utah USA Specialized interventional and access device provider Embolization devices, microcatheters
Penumbra Alameda, California USA Neurovascular and peripheral intervention devices Thrombectomy systems
AngioDynamics Latham, New York USA Vascular access and oncology-related interventional tools Catheters, ablation systems
CathWorks Kfar Saba Israel AI-driven coronary physiology assessment in cath labs FFRangio computational physiology platform
HeartFlow Mountain View, California USA AI-based coronary artery disease diagnostic support FFR-CT analysis for pre-cath planning

Recent Developments in the U.S. Cath Labs Market

  • In April 2026, after the 510(k) U.S. Food and Drug Administration (FDA) clearance, the Synchrony system was launched by Stereotaxis for cath laboratories. The system offers a 55-inch 4K ultra-high-definition display, an intuitive user interface, customisable layouts, and improved workflow, promoting advanced digital capabilities in interventional cath labs.
  • In October 2025, YorLabs Intracardiac Imaging System, which is a first-of-its-kind, zero-capex ultrasound platform, was announced to have received U.S. FDA 510(k) clearance by YorLabs, Inc. The platform helps in enhancing procedural efficiency, simplifying workflow, and reducing cost inside the cath lab.

U.S. Cath Labs Market Value Chain Analysis

R&D

  • The R&D of the U.S. cath labs focuses on the development of next-generation PFA ablation systems, robotic-assisted intervention, transcatheter structural heart devices, and AI integration.
  • Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Clinical Trials and Regulatory Approvals

  • The clinical safety, procedural efficacy, radiation dose reduction, and long-term durability are evaluated in the clinical trials and regulatory approvals of the U.S. cath labs.
  • Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Patient Support and Services

  • Multilingual patient education applications, post-discharge digital monitoring platforms, and dedicated financial reimbursement navigation lines are provided in the patient support and services of the U.S. cath labs.
  • Key players: Abbott Laboratories, Medtronic plc, Boston Scientific Corporation.

Market Ecosystem Analysis

Ecosystem Segment Key Participants Role in Market
Technology Providers GE HealthCare, Siemens Healthineers Provide imaging systems, fluoroscopy, cath lab infrastructure
Product Manufacturers Boston Scientific, Abbott Laboratories Manufacture stents, catheters, structural heart devices
Service Providers Hospital networks, biomedical engineering firms Installation, maintenance, and operational support of cath labs
Platform Providers Philips, HeartFlow Image-guided therapy platforms, AI-based diagnostic support
CROs/CDMOs Limited relevance in cath labs Not directly applicable; more relevant in pharma
Software Vendors HeartFlow, GE digital imaging divisions AI-based cardiac imaging, FFR-CT, workflow optimization
Research Institutions Cleveland Clinic, Mayo Clinic, Johns Hopkins Medicine Clinical trials, procedural innovation, training
End-User Industries Hospitals, cardiac centers, ASCs Primary utilization of cath lab infrastructure

Market Growth

The U.S. cath labs market size was estimated at USD 6.84 billion in 2025 and is predicted to increase from USD 7.31 billion in 2026 to approximately USD 13.33 billion by 2035, expanding at a CAGR of 6.9% from 2026 to 2035.

U.S. Cath Labs Market Size is USD 7.31 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales